These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7546526)

  • 41. A comparison of solute clearance during continuous hemofiltration, hemodiafiltration, and hemodialysis using a polysulfone hemofilter.
    Reeves JH; Butt WW
    ASAIO J; 1995; 41(1):100-4. PubMed ID: 7727810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The hemodynamic effect of different ultrafiltration rates in patients with cardiac failure and patients without cardiac failure: comparison between isolated ultrafiltration and ultrafiltration with dialysis.
    van der Sande FM; Mulder AW; Hoorntje SJ; Peels KH; van Kuijk WH; Kooman JP; Leunissen KM
    Clin Nephrol; 1998 Nov; 50(5):301-8. PubMed ID: 9840318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Remarkable removal of beta-2-microglobulin by on-line hemodiafiltration.
    Lornoy W; Becaus I; Billiouw JM; Sierens L; van Malderen P
    Am J Nephrol; 1998; 18(2):105-8. PubMed ID: 9569951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
    Level C; Chauveau P; Guisset O; Cazin MC; Lasseur C; Gabinsky C; Winnock S; Montaudon D; Bedry R; Nouts C; Pillet O; Benissan GG; Favarel-Guarrigues JC; Castaing Y
    Crit Care; 2003 Dec; 7(6):R160-6. PubMed ID: 14624691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rationale and experience with short daily hemofiltration.
    Jaber BL; Zimmerman DL
    Semin Dial; 2004; 17(2):146-50. PubMed ID: 15043618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Real-time circuit pressures correlate poorly with circuit longevity in anticoagulant-free, predilution continuous venovenous hemofiltration.
    Tan CS; Tan HK; Choong HL
    Blood Purif; 2011; 32(1):15-20. PubMed ID: 21252502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predilution hemofiltration. Clinical experience and removal of small molecular weight solutes.
    David S; Boström M; Cambi V
    Int J Artif Organs; 1995 Nov; 18(11):743-50. PubMed ID: 8964639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G; Jaber BL
    Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Ways of intensification of hemodialysis therapy].
    Filiptsev PIa; Kirkhman VV; Timokhov VS
    Ter Arkh; 1988; 60(6):44-7. PubMed ID: 3206368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic hemofiltration. A critical evaluation of a new method for the treatment of blood.
    Schaefer K; von Herrath D; Gullberg CA; Asmus G; Hüfler M; Offermann G; Cremer H; Heuck CC; Ritz E
    Artif Organs; 1978 Nov; 2(4):386-94. PubMed ID: 743012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contributions to biorheology during hemodialysis.
    Seyfert UT; Hauck W; Kirsch J; Kiesewetter H; Albert FW; Wenzel E
    Biorheology; 1991; 28(5):473-81. PubMed ID: 1782397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical evaluation of a multipurpose dialysis system adequate for hemodialysis or for postdilution hemofiltration/hemodiafiltration with on-line preparation of substitution fluid from dialysate.
    Canaud B; N'Guyen QV; Lagarde C; Stec F; Polaschegg HD; Mion C
    Contrib Nephrol; 1985; 46():184-6. PubMed ID: 4006477
    [No Abstract]   [Full Text] [Related]  

  • 54. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of metabolic alkalosis with hemofiltration in patients with renal insufficiency.
    Kheirbek AO; Ing TS; Viol GW; Vilbar RM; Bansal VK; Gandhi VC; Geis WP; Hano JE
    Nephron; 1979; 24(2):91-2. PubMed ID: 492418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Membrane designs and composition for hemodialysis, hemofiltration and hemodialfiltration: past, present and future.
    Davenport A
    Minerva Urol Nefrol; 2010 Mar; 62(1):29-40. PubMed ID: 20424568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effectiveness of low-volume hemofiltration in treating severe arterial hypertension with initial manifestations of renal failure].
    Kutsenko AI; Zaruba AIu; Kukharchuk VV; Arabidze GG; Chuĭkin NA
    Kardiologiia; 1989 Apr; 29(4):31-3. PubMed ID: 2754911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computational dose predictions for combined treatment of hemofiltration with weekly hemodialysis.
    Lee JC; Park CY; Choi SW; Park JY; Kim JC; Yun YM; Lee KK; Sun K; Min BG
    Comput Methods Programs Biomed; 2008 Mar; 89(3):275-81. PubMed ID: 18155799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hemodiafiltration with high-level ultrafiltration versus hemodialysis. Longitudinal study].
    Gonella M; Calabrese G; Mazzotta A; Pratesi G; Vagelli G
    Minerva Urol Nefrol; 1990; 42(1):31-4. PubMed ID: 2389220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous arteriovenous and intermittent hemofiltration in renal failure.
    Alarabi AA
    Scand J Urol Nephrol Suppl; 1990; 127():1-55. PubMed ID: 2255868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.